These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 513321)

  • 1. [Blood coagulation analysis using laser nephelometry (author's transl)].
    Suenaga R
    Rinsho Byori; 1979 Sep; 27(9):766-73. PubMed ID: 513321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of coagulofibrinolytic factors by laser nephelometry (author's transl)].
    Nakamura K; Tokuda M; Iijima K
    Rinsho Byori; 1981; 29(7):655-61. PubMed ID: 7328798
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of alpha2-macroglobulin and FDP on the antithrombin III assay system (author's transl)].
    Yoshida N; Tachiya K; Moroi M; Matsuda M; Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):197-201. PubMed ID: 70144
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of a thrombotic tendency by means of coagulation tests (author's transl)].
    von Kaulla E; von Kaulla KN
    MMW Munch Med Wochenschr; 1974 Aug; 116(31):1387-96. PubMed ID: 4212608
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of an abnormal plasma clot structure by a simple rigidity assay.
    Carr ME; Blatt PM; Roberts HR; Brooker JZ; Hermans J
    Thromb Haemost; 1979 Oct; 42(3):965-71. PubMed ID: 505410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrinogen and fibrin degradation products by leukocyte elastase].
    Madoiwa S; Sakata Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():611-4. PubMed ID: 15658403
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coagulant and procoagulant factors in ascitic fluid--about etiology DIC induced by ascitic fluid infusion (author's transl)].
    Ojiro M
    Igaku Kenkyu; 1981 Oct; 51(4):177-85. PubMed ID: 7331734
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N
    Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of the nature of hemostatic failure during transplantation of the liver.
    Dugdale M; Britt LG; Vera SR; Peters TG; Williams J; Zimmermann AG; Gaber AO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2332-3. PubMed ID: 2652756
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of fibrinogen-metabolism products].
    Stemberger A; Blümel G
    Med Welt; 1978 Feb; 29(6):216-9. PubMed ID: 622028
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical application of laser-nephelometry method--studies of application to selectivity of proteinuria (author's transl)].
    Ishimoto S; Yamasaki S
    Rinsho Byori; 1979 Sep; 27(9):762-5. PubMed ID: 513320
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation tests ].
    Fukue H; Fukutake K
    Rinsho Byori; 1997 Nov; Suppl():99-106. PubMed ID: 9508613
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specificity and sensitivity of paracoagulation tests].
    Litvinov RI; Voronina IE; Gabitov SE
    Lab Delo; 1980; (11):662-6. PubMed ID: 6160297
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coagulation factors in human born blisters (author's transl)].
    Burkhardt H; Zellner PR
    Blut; 1977 Sep; 35(3):241-6. PubMed ID: 912108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of the prethrombotic state in clinical practice].
    Makatsariia AD; Mishchenko AL
    Sov Med; 1982; (6):56-60. PubMed ID: 6750807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of microtechnics in the study of coagulation].
    Mizrahi Mograbi L; Méndez JA; Pizuto Chávez J
    Bol Med Hosp Infant Mex; 1981; 38(1):87-101. PubMed ID: 7284077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of fibrin degradation products on different biological tests (author's transl)].
    Vila V; Aznar J; Regañon E
    Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.